Literature DB >> 34604199

Iris Melanoma in a Patient with Retinitis Pigmentosa.

Hiroshi Goto1, Naoyuki Yamakawa1.   

Abstract

This report describes the histopathological findings of an iris melanoma that developed in a patient with retinitis pigmentosa (RP). A 66-year-old man was referred to our hospital with a diagnosis of iris tumor. He had a medical history of RP for over 25 years. His best corrected visual acuity at presentation was 20/20 (OD) and 20/200 (OS). Slit lamp examination revealed an iris melanocytoma in his right eye and a brown iris mass involving the pupil in his left eye. Ocular fundus examination of his right eye showed diffuse chorioretinal atrophy with attenuated retinal vessels and scattered pigment. A diagnosis of iris melanoma was made and enucleation of his left eyeball was performed. Histopathological examination of the eyeball showed an iris tumor with proliferation of spindle cells positive for Melan-A, HMB-45, and S-100 protein by immunohistochemistry. Diffuse destruction of retinal architecture was observed, with loss of outer segment and replacement by glial cells. Accumulation of melanin pigment around retinal vessels was found in peripheral retina. These histopathological findings were compatible with advanced stage of RP. This case demonstrates that iris melanoma can occur in eye with RP.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Histopathology; Iris melanoma; Retinitis pigmentosa

Year:  2021        PMID: 34604199      PMCID: PMC8443924          DOI: 10.1159/000511550

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  11 in total

1.  Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.

Authors:  Carol L Shields; Swathi Kaliki; Minoru Furuta; Arman Mashayekhi; Jerry A Shields
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

2.  Choroidal melanoma in a patient with retinitis pigmentosa and Usher's syndrome.

Authors:  K Gündüz; J A Shields; C L Shields; D Y Zhao
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

3.  Iris melanoma: features and prognosis in 317 children and adults.

Authors:  Carol L Shields; Swathi Kaliki; Sanket U Shah; Wenjuan Luo; Minoru Furuta; Jerry A Shields
Journal:  J AAPOS       Date:  2012-02       Impact factor: 1.220

4.  Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.

Authors:  H Goto; M Usui; I Ishii
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

5.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors:  Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

6.  Melanoma of the iris: report of 72 cases treated surgically.

Authors:  J J Arentsen; W R Green
Journal:  Ophthalmic Surg       Date:  1975

7.  [Pseudoneuritis pigmentosa in malignant melanoma of the choroid].

Authors:  P K Lommatzsch; O A Jensen; J U Prause; G Bauke
Journal:  Klin Monbl Augenheilkd       Date:  1988-07       Impact factor: 0.700

8.  Pseudoretinitis pigmentosa secondary to preretinal malignant melanoma cells.

Authors:  R C Eagle; J A Shields
Journal:  Retina       Date:  1982       Impact factor: 4.256

9.  Tumors of the anterior uvea. I. Metastasizing malignant melanoma of the iris.

Authors:  M S Sunba; A H Rahi; G Morgan
Journal:  Arch Ophthalmol       Date:  1980-01

Review 10.  Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture.

Authors:  C L Shields; S Kaliki; M N Cohen; P W Shields; M Furuta; J A Shields
Journal:  Eye (Lond)       Date:  2015-08-07       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.